- Home
- MYO vs AMRN Comparison
MYO vs AMRN Comparison
Compare MYO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- AMRN
- Stock Information
- Founded
- MYO 2004
- AMRN 1989
- Country
- MYO United States
- AMRN Ireland
- Employees
- MYO N/A
- AMRN N/A
- Industry
- MYO Industrial Specialties
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- MYO Health Care
- AMRN Health Care
- Exchange
- MYO Nasdaq
- AMRN Nasdaq
- Market Cap
- MYO 157.9M
- AMRN 189.2M
- IPO Year
- MYO 2017
- AMRN 1993
- Fundamental
- Price
- MYO $6.02
- AMRN $0.57
- Analyst Decision
- MYO Strong Buy
- AMRN Buy
- Analyst Count
- MYO 4
- AMRN 1
- Target Price
- MYO $8.25
- AMRN N/A
- AVG Volume (30 Days)
- MYO 400.7K
- AMRN 1.7M
- Earning Date
- MYO 03-06-2025
- AMRN 02-27-2025
- Dividend Yield
- MYO N/A
- AMRN N/A
- EPS Growth
- MYO N/A
- AMRN N/A
- EPS
- MYO N/A
- AMRN N/A
- Revenue
- MYO $25,239,125.00
- AMRN $241,021,000.00
- Revenue This Year
- MYO $59.01
- AMRN N/A
- Revenue Next Year
- MYO $40.60
- AMRN N/A
- P/E Ratio
- MYO N/A
- AMRN N/A
- Revenue Growth
- MYO 36.23
- AMRN N/A
- 52 Week Low
- MYO $2.51
- AMRN $0.43
- 52 Week High
- MYO $7.17
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- MYO 47.56
- AMRN 57.07
- Support Level
- MYO $5.86
- AMRN $0.43
- Resistance Level
- MYO $6.31
- AMRN $0.49
- Average True Range (ATR)
- MYO 0.37
- AMRN 0.04
- MACD
- MYO -0.11
- AMRN 0.01
- Stochastic Oscillator
- MYO 14.62
- AMRN 84.62
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.